| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.83 | 0.007 | 0.83 | Caspase 9 stimulant | 0.829 0.007 CID_154699774 0.829 0.007 CID_154699519 | ||
| 0.762 | 0.004 | 0.827 | Free radical scavenger | 0.827 0.004 CID_154699774 0.827 0.004 CID_154699519 | CID_154699519 | |
| 0.756 | 0.004 | 0.756 | Superoxide dismutase inhibitor | 0.255 0.071 CID_154699774 0.255 0.071 CID_154699519 | ||
| 0.757 | 0.005 | 0.871 | Antioxidant | 0.871 0.004 CID_154699774 0.871 0.004 CID_154699519 | CID_154699519 | |
| 0.74 | 0.005 | 0.74 | Amyloid beta aggregation inhibitor | 0.54 0.011 CID_154699774 0.54 0.011 CID_154699519 | ||
| 0.715 | 0.028 | 0.778 | Apoptosis agonist | 0.778 0.019 CID_154699774 0.778 0.019 CID_154699519 | CID_154699519 | |
| 0.687 | 0.002 | 0.687 | Succinate dehydrogenase inhibitor | 0.239 0.026 CID_154699774 0.239 0.026 CID_154699519 | ||
| 0.677 | 0.002 | 0.677 | Cystathionine beta-synthase inhibitor | 0.563 0.003 CID_154699774 0.563 0.003 CID_154699519 | ||
| 0.673 | 0.004 | 0.673 | NOS3 expression enhancer | 0.653 0.004 CID_154699774 0.653 0.004 CID_154699519 | ||
| 0.668 | 0.011 | 0.668 | Aldehyde oxidase inhibitor | |||
| 0.674 | 0.024 | 0.91 | Transcription factor NF kappa B inhibitor | 0.91 0.005 CID_154699774 0.91 0.005 CID_154699519 | CID_154699519 | |
| 0.652 | 0.012 | 0.755 | Cholesterol antagonist | 0.755 0.005 CID_154699774 0.755 0.005 CID_154699519 | CID_154699519 | |
| 0.647 | 0.011 | 0.647 | Vasodilator, peripheral | 0.642 0.011 CID_154699774 0.642 0.011 CID_154699519 | ||
| 0.662 | 0.038 | 0.852 | Antiinflammatory | 0.852 0.009 CID_154699774 0.852 0.009 CID_154699519 | CID_154699519 | |
| 0.617 | 0.009 | 0.77 | Histamine release inhibitor | 0.77 0.004 CID_154699774 0.77 0.004 CID_154699519 | CID_154699519 | |
| 0.611 | 0.009 | 0.611 | Lipoxygenase inhibitor | 0.188 0.153 CID_154699774 0.188 0.153 CID_154699519 | ||
| 0.603 | 0.005 | 0.881 | Monophenol monooxygenase inhibitor | 0.881 0.002 CID_154699774 0.881 0.002 CID_154699519 | CID_154699519 | |
| 0.602 | 0.009 | 0.648 | Apoptosis antagonist | 0.648 0.005 CID_154699774 0.648 0.005 CID_154699519 | CID_154699519 | |
| 0.582 | 0.005 | 0.582 | Peroxidase inhibitor | |||
| 0.577 | 0.003 | 0.577 | Carbonic anhydrase VI inhibitor | 0.349 0.005 CID_154699774 0.349 0.005 CID_154699519 | ||
| 0.548 | 0.003 | 0.548 | Carbonic anhydrase III inhibitor | 0.342 0.005 CID_154699774 0.342 0.005 CID_154699519 | ||
| 0.548 | 0.003 | 0.548 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.576 | 0.032 | 0.84 | Cyclophilin D inhibitor | 0.84 0.005 CID_154699774 0.84 0.005 CID_154699519 | CID_154699519 | |
| 0.543 | 0.003 | 0.543 | GABA C receptor agonist | 0.094 0.074 CID_154699774 0.094 0.074 CID_154699519 | ||
| 0.544 | 0.012 | 0.752 | Hypoglycemic | 0.752 0.004 CID_154699774 0.752 0.004 CID_154699519 | CID_154699519 | |
| 0.533 | 0.005 | 0.803 | Amylase inhibitor | 0.803 0.002 CID_154699774 0.803 0.002 CID_154699519 | CID_154699519 | |
| 0.529 | 0.003 | 0.529 | HIV-1 integrase (3'-Processing) inhibitor | 0.268 0.006 CID_154699774 0.268 0.006 CID_154699519 | ||
| 0.524 | 0.006 | 0.727 | Melanin inhibitor | 0.727 0.003 CID_154699774 0.727 0.003 CID_154699519 | CID_154699519 | |
| 0.536 | 0.024 | 0.847 | Antithrombotic | 0.847 0.003 CID_154699774 0.847 0.003 CID_154699519 | CID_154699519 | |
| 0.506 | 0.006 | 0.506 | Phospholipase C inhibitor | 0.341 0.015 CID_154699774 0.341 0.015 CID_154699519 | ||
| 0.483 | 0.003 | 0.483 | Histidine decarboxylase inhibitor | 0.097 0.033 CID_154699774 0.097 0.033 CID_154699519 | ||
| 0.482 | 0.006 | 0.558 | Platelet adhesion inhibitor | 0.558 0.004 CID_154699774 0.558 0.004 CID_154699519 | CID_154699519 | |
| 0.478 | 0.009 | 0.48 | Anesthetic general | 0.48 0.009 CID_154699774 0.48 0.009 CID_154699519 | CID_154699519 | |
| 0.469 | 0.006 | 0.514 | Alpha-N-acetylglucosaminidase inhibitor | 0.514 0.005 CID_154699774 0.514 0.005 CID_154699519 | CID_154699519 | |
| 0.459 | 0.003 | 0.459 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 CID_154699774 0.077 0.04 CID_154699519 | ||
| 0.459 | 0.003 | 0.459 | Prostaglandin EP2 antagonist | 0.234 0.005 CID_154699774 0.234 0.005 CID_154699519 | ||
| 0.457 | 0.003 | 0.457 | Keratolytic | 0.111 0.025 CID_154699774 0.111 0.025 CID_154699519 | ||
| 0.463 | 0.012 | 0.463 | Pyruvate kinase inhibitor | 0.163 0.105 CID_154699774 0.163 0.105 CID_154699519 | ||
| 0.466 | 0.019 | 0.605 | Antiamyloidogenic | 0.605 0.008 CID_154699774 0.605 0.008 CID_154699519 | CID_154699519 | |
| 0.449 | 0.005 | 0.449 | Chelator | 0.188 0.027 CID_154699774 0.188 0.027 CID_154699519 | ||
| 0.468 | 0.025 | 0.468 | Caspase 3 stimulant | 0.449 0.03 CID_154699774 0.449 0.03 CID_154699519 | ||
| 0.486 | 0.044 | 0.486 | 15-Lipoxygenase inhibitor | |||
| 0.441 | 0.005 | 0.441 | 5-Lipoxygenase inhibitor | |||
| 0.451 | 0.019 | 0.5 | Platelet antagonist | 0.5 0.014 CID_154699774 0.5 0.014 CID_154699519 | CID_154699519 | |
| 0.439 | 0.008 | 0.5 | Lipid peroxidase inhibitor | 0.5 0.005 CID_154699774 0.5 0.005 CID_154699519 | CID_154699519 | |
| 0.449 | 0.02 | 0.631 | Nitric oxide antagonist | 0.631 0.008 CID_154699774 0.631 0.008 CID_154699519 | CID_154699519 | |
| 0.429 | 0.004 | 0.429 | HIV-1 integrase (Strand Transfer) inhibitor | 0.24 0.007 CID_154699774 0.24 0.007 CID_154699519 | ||
| 0.424 | 0.005 | 0.424 | Insulin sensitizer | 0.322 0.012 CID_154699774 0.322 0.012 CID_154699519 | ||
| 0.458 | 0.039 | 0.458 | GABA C receptor rho-3 antagonist | |||
| 0.425 | 0.007 | 0.425 | Protein-tyrosine phosphatase inhibitor | 0.299 0.019 CID_154699774 0.299 0.019 CID_154699519 | ||
| 0.43 | 0.027 | 0.627 | Vasodilator, coronary | 0.627 0.006 CID_154699774 0.627 0.006 CID_154699519 | CID_154699519 | |
| 0.405 | 0.003 | 0.405 | Glutamate decarboxylase inhibitor | 0.087 0.038 CID_154699774 0.087 0.038 CID_154699519 | ||
| 0.413 | 0.012 | 0.413 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.402 | 0.004 | 0.521 | Carbonic anhydrase XIII inhibitor | 0.521 0.003 CID_154699774 0.521 0.003 CID_154699519 | CID_154699519 | |
| 0.403 | 0.028 | 0.423 | DNA damaging | 0.423 0.024 CID_154699774 0.423 0.024 CID_154699519 | CID_154699519 | |
| 0.404 | 0.03 | 0.404 | Interleukin antagonist | 0.202 0.083 CID_154699774 0.202 0.083 CID_154699519 | ||
| 0.378 | 0.006 | 0.378 | M18 aspartyl aminopeptidase inhibitor | 0.127 0.065 CID_154699774 0.127 0.065 CID_154699519 | ||
| 0.379 | 0.01 | 0.52 | Protein kinase stimulant | 0.52 0.004 CID_154699774 0.52 0.004 CID_154699519 | CID_154699519 | |
| 0.431 | 0.063 | 0.705 | Antibacterial | 0.705 0.008 CID_154699774 0.705 0.008 CID_154699519 | CID_154699519 | |
| 0.373 | 0.005 | 0.373 | Cholesterol synthesis inhibitor | 0.287 0.013 CID_154699774 0.287 0.013 CID_154699519 | ||
| 0.389 | 0.025 | 0.505 | Vasodilator | 0.505 0.012 CID_154699774 0.505 0.012 CID_154699519 | CID_154699519 | |
| 0.382 | 0.022 | 0.48 | Interleukin agonist | 0.48 0.01 CID_154699774 0.48 0.01 CID_154699519 | CID_154699519 | |
| 0.399 | 0.039 | 0.399 | 12-Lipoxygenase inhibitor | |||
| 0.383 | 0.025 | 0.383 | Insulysin inhibitor | |||
| 0.355 | 0.004 | 0.355 | Porphobilinogen synthase inhibitor | |||
| 0.37 | 0.026 | 0.37 | Transcription factor STAT3 inhibitor | 0.186 0.155 CID_154699774 0.186 0.155 CID_154699519 | ||
| 0.344 | 0.003 | 0.356 | Heat shock protein 70 antagonist | 0.356 0.003 CID_154699774 0.356 0.003 CID_154699519 | CID_154699519 | |
| 0.354 | 0.018 | 0.611 | Hepatoprotectant | 0.611 0.004 CID_154699774 0.611 0.004 CID_154699519 | CID_154699519 | |
| 0.341 | 0.005 | 0.341 | Estrogen antagonist | 0.146 0.025 CID_154699774 0.146 0.025 CID_154699519 | ||
| 0.342 | 0.008 | 0.342 | Protein-tyrosine phosphatase 1B inhibitor | 0.261 0.015 CID_154699774 0.261 0.015 CID_154699519 | ||
| 0.348 | 0.014 | 0.544 | DNA methyltransferase I inhibitor | 0.544 0.004 CID_154699774 0.544 0.004 CID_154699519 | CID_154699519 | |
| 0.36 | 0.03 | 0.36 | Transcription factor STAT inhibitor | |||
| 0.337 | 0.009 | 0.337 | Interleukin 1 antagonist | 0.181 0.042 CID_154699774 0.181 0.042 CID_154699519 | ||
| 0.358 | 0.034 | 0.402 | Hypolipemic | 0.402 0.025 CID_154699774 0.402 0.025 CID_154699519 | CID_154699519 | |
| 0.332 | 0.009 | 0.332 | DNA polymerase I inhibitor | 0.272 0.014 CID_154699774 0.272 0.014 CID_154699519 | ||
| 0.354 | 0.031 | 0.824 | Angiogenesis stimulant | 0.824 0.004 CID_154699774 0.824 0.004 CID_154699519 | CID_154699519 | |
| 0.324 | 0.005 | 0.324 | ABCA1 expression enhancer | 0.1 0.05 CID_154699774 0.1 0.05 CID_154699519 | ||
| 0.325 | 0.007 | 0.741 | Expectorant | 0.741 0.002 CID_154699774 0.741 0.002 CID_154699519 | CID_154699519 | |
| 0.397 | 0.08 | 0.437 | 5 Hydroxytryptamine release inhibitor | 0.437 0.058 CID_154699774 0.437 0.058 CID_154699519 | CID_154699519 | |
| 0.365 | 0.048 | 0.515 | Spasmolytic | 0.515 0.021 CID_154699774 0.515 0.021 CID_154699519 | CID_154699519 | |
| 0.359 | 0.042 | 0.387 | Hypoxia-inducible factor 1 alpha inhibitor | 0.387 0.034 CID_154699774 0.387 0.034 CID_154699519 | CID_154699519 | |
| 0.353 | 0.038 | 0.353 | Sodium/bile acid cotransporter inhibitor | 0.228 0.153 CID_154699774 0.228 0.153 CID_154699519 | ||
| 0.321 | 0.006 | 0.545 | Xanthine oxidase inhibitor | 0.545 0.003 CID_154699774 0.545 0.003 CID_154699519 | CID_154699519 | |
| 0.32 | 0.006 | 0.663 | Mediator release inhibitor | 0.663 0.003 CID_154699774 0.663 0.003 CID_154699519 | CID_154699519 | |
| 0.318 | 0.004 | 0.318 | Macrophage migration inhibitory factor inhibitor | |||
| 0.358 | 0.045 | 0.358 | Calcium channel activator | |||
| 0.331 | 0.02 | 0.541 | DNA methylase inhibitor | 0.541 0.005 CID_154699774 0.541 0.005 CID_154699519 | CID_154699519 | |
| 0.326 | 0.017 | 0.5 | Interferon gamma antagonist | 0.5 0.006 CID_154699774 0.5 0.006 CID_154699519 | CID_154699519 | |
| 0.321 | 0.013 | 0.374 | Neurotrophic factor enhancer | 0.374 0.007 CID_154699774 0.374 0.007 CID_154699519 | CID_154699519 | |
| 0.324 | 0.017 | 0.324 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.265 0.036 CID_154699774 0.265 0.036 CID_154699519 | ||
| 0.373 | 0.075 | 0.538 | Immunosuppressant | 0.538 0.023 CID_154699774 0.538 0.023 CID_154699519 | CID_154699519 | |
| 0.301 | 0.004 | 0.301 | Alcohol oxidase inhibitor | |||
| 0.32 | 0.024 | 0.599 | Non-steroidal antiinflammatory agent | 0.599 0.004 CID_154699774 0.599 0.004 CID_154699519 | CID_154699519 | |
| 0.308 | 0.012 | 0.308 | Phospholipase A2 inhibitor | 0.229 0.03 CID_154699774 0.229 0.03 CID_154699519 | ||
| 0.323 | 0.037 | 0.456 | DNA synthesis inhibitor | 0.456 0.017 CID_154699774 0.456 0.017 CID_154699519 | CID_154699519 | |
| 0.289 | 0.006 | 0.289 | Mannose-6-phosphate isomerase inhibitor | 0.28 0.007 CID_154699774 0.28 0.007 CID_154699519 | ||
| 0.283 | 0.003 | 0.283 | Ornithine decarboxylase inhibitor | 0.169 0.007 CID_154699774 0.169 0.007 CID_154699519 | ||
| 0.284 | 0.004 | 0.284 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.289 | 0.009 | 0.289 | Interleukin 1b antagonist | 0.179 0.025 CID_154699774 0.179 0.025 CID_154699519 | ||
| 0.281 | 0.004 | 0.281 | Carbonic anhydrase V inhibitor | 0.059 0.055 CID_154699774 0.059 0.055 CID_154699519 | ||
| 0.299 | 0.025 | 0.435 | Peptidyltransferase inhibitor | 0.435 0.005 CID_154699774 0.435 0.005 CID_154699519 | CID_154699519 | |
| 0.277 | 0.005 | 0.277 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.281 | 0.009 | 0.281 | Ferrochelatase inhibitor | |||
| 0.296 | 0.029 | 0.296 | Dual specificity phosphatase 3 inhibitor | |||
| 0.273 | 0.007 | 0.273 | Catalase inhibitor | |||
| 0.285 | 0.021 | 0.285 | Tubulin antagonist | |||
| 0.385 | 0.121 | 0.739 | Alpha-glucosidase inhibitor | 0.739 0.027 CID_154699774 0.739 0.027 CID_154699519 | CID_154699519 | |
| 0.293 | 0.03 | 0.293 | P-glycoprotein inhibitor | 0.253 0.04 CID_154699774 0.253 0.04 CID_154699519 | ||
| 0.312 | 0.049 | 0.649 | Tumour necrosis factor alpha release inhibitor | 0.649 0.005 CID_154699774 0.649 0.005 CID_154699519 | CID_154699519 | |
| 0.264 | 0.004 | 0.264 | Carbonic anhydrase VB inhibitor | |||
| 0.264 | 0.005 | 0.264 | Vanilloid 1 agonist | 0.228 0.007 CID_154699774 0.228 0.007 CID_154699519 | ||
| 0.32 | 0.061 | 0.45 | Interleukin 2 agonist | 0.45 0.015 CID_154699774 0.45 0.015 CID_154699519 | CID_154699519 | |
| 0.288 | 0.031 | 0.288 | Dual specificity phosphatase inhibitor | |||
| 0.259 | 0.004 | 0.259 | HIV-1 integrase inhibitor | 0.128 0.013 CID_154699774 0.128 0.013 CID_154699519 | ||
| 0.272 | 0.018 | 0.272 | Cyclooxygenase 1 inhibitor | 0.168 0.048 CID_154699774 0.168 0.048 CID_154699519 | ||
| 0.258 | 0.004 | 0.258 | Glutathione S-transferase inhibitor | 0.138 0.015 CID_154699774 0.138 0.015 CID_154699519 | ||
| 0.255 | 0.003 | 0.255 | Prostaglandin EP3 antagonist | 0.038 0.015 CID_154699774 0.038 0.015 CID_154699519 | ||
| 0.275 | 0.024 | 0.275 | Amyloid beta precursor protein antagonist | |||
| 0.255 | 0.008 | 0.255 | Toll-Like receptor 2 antagonist | 0.134 0.065 CID_154699774 0.134 0.065 CID_154699519 | ||
| 0.25 | 0.004 | 0.25 | GABA aminotransferase inhibitor | 0.161 0.006 CID_154699774 0.161 0.006 CID_154699519 | ||
| 0.26 | 0.014 | 0.415 | Cell adhesion inhibitor | 0.415 0.005 CID_154699774 0.415 0.005 CID_154699519 | CID_154699519 | |
| 0.249 | 0.004 | 0.249 | Adenylate cyclase stimulant | 0.183 0.023 CID_154699774 0.183 0.023 CID_154699519 | ||
| 0.249 | 0.004 | 0.249 | Leukotriene antagonist | 0.188 0.006 CID_154699774 0.188 0.006 CID_154699519 | ||
| 0.26 | 0.018 | 0.375 | Insulin secretagoues | 0.375 0.007 CID_154699774 0.375 0.007 CID_154699519 | CID_154699519 | |
| 0.247 | 0.005 | 0.247 | Creatine kinase inhibitor | |||
| 0.244 | 0.004 | 0.244 | Carbonic anhydrase VA inhibitor | 0.067 0.05 CID_154699774 0.067 0.05 CID_154699519 | ||
| 0.252 | 0.013 | 0.391 | ATPase inhibitor | 0.391 0.004 CID_154699774 0.391 0.004 CID_154699519 | CID_154699519 | |
| 0.267 | 0.03 | 0.267 | Mcl-1 antagonist | |||
| 0.244 | 0.008 | 0.244 | Uric acid excretion stimulant | 0.226 0.01 CID_154699774 0.226 0.01 CID_154699519 | ||
| 0.24 | 0.004 | 0.24 | DOPA decarboxylase inhibitor | |||
| 0.24 | 0.005 | 0.24 | Aldose reductase inhibitor | 0.219 0.006 CID_154699774 0.219 0.006 CID_154699519 | ||
| 0.24 | 0.008 | 0.24 | Arachidonic acid antagonist | 0.18 0.054 CID_154699774 0.18 0.054 CID_154699519 | ||
| 0.248 | 0.019 | 0.248 | Adenylate cyclase inhibitor | 0.155 0.042 CID_154699774 0.155 0.042 CID_154699519 | ||
| 0.278 | 0.051 | 0.278 | Gastrin inhibitor | |||
| 0.277 | 0.051 | 0.277 | Antimitotic | 0.142 0.13 CID_154699774 0.142 0.13 CID_154699519 | ||
| 0.244 | 0.019 | 0.244 | Aldehyde dehydrogenase inhibitor | 0.2 0.028 CID_154699774 0.2 0.028 CID_154699519 | ||
| 0.255 | 0.029 | 0.264 | Nitric-oxide synthase stimulant | 0.264 0.024 CID_154699774 0.264 0.024 CID_154699519 | CID_154699519 | |
| 0.228 | 0.004 | 0.228 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.189 0.004 CID_154699774 0.189 0.004 CID_154699519 | ||
| 0.229 | 0.005 | 0.229 | Prolactin inhibitor | |||
| 0.229 | 0.009 | 0.303 | Phosphofructokinase-1 inhibitor | 0.303 0.005 CID_154699774 0.303 0.005 CID_154699519 | CID_154699519 | |
| 0.287 | 0.068 | 0.287 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.222 | 0.004 | 0.222 | Xanthine dehydrogenase inhibitor | 0.101 0.015 CID_154699774 0.101 0.015 CID_154699519 | ||
| 0.221 | 0.004 | 0.376 | Carbonic anhydrase XIV inhibitor | 0.376 0.003 CID_154699774 0.376 0.003 CID_154699519 | CID_154699519 | |
| 0.228 | 0.012 | 0.228 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.211 0.014 CID_154699774 0.211 0.014 CID_154699519 | ||
| 0.226 | 0.01 | 0.698 | Beta glucuronidase inhibitor | 0.698 0.002 CID_154699774 0.698 0.002 CID_154699519 | CID_154699519 | |
| 0.223 | 0.009 | 0.301 | Triose-phosphate isomerase inhibitor | 0.301 0.005 CID_154699774 0.301 0.005 CID_154699519 | CID_154699519 | |
| 0.224 | 0.015 | 0.241 | Microtubule formation inhibitor | 0.241 0.011 CID_154699774 0.241 0.011 CID_154699519 | CID_154699519 | |
| 0.214 | 0.009 | 0.214 | Glutamate dehydrogenase inhibitor | 0.102 0.03 CID_154699774 0.102 0.03 CID_154699519 | ||
| 0.213 | 0.008 | 0.213 | TRPA1 agonist | 0.148 0.033 CID_154699774 0.148 0.033 CID_154699519 | ||
| 0.209 | 0.004 | 0.209 | Transcription factor AP-1 inhibitor | 0.148 0.007 CID_154699774 0.148 0.007 CID_154699519 | ||
| 0.219 | 0.016 | 0.219 | Carbonic anhydrase XV inhibitor | |||
| 0.283 | 0.084 | 0.533 | Immunostimulant | 0.533 0.025 CID_154699774 0.533 0.025 CID_154699519 | CID_154699519 | |
| 0.226 | 0.034 | 0.226 | MAO inhibitor | |||
| 0.225 | 0.032 | 0.225 | Cyclooxygenase inhibitor | 0.149 0.071 CID_154699774 0.149 0.071 CID_154699519 | ||
| 0.202 | 0.013 | 0.219 | Mucolytic | 0.219 0.01 CID_154699774 0.219 0.01 CID_154699519 | CID_154699519 | |
| 0.195 | 0.007 | 0.211 | Toll-Like receptor 4 antagonist | 0.211 0.005 CID_154699774 0.211 0.005 CID_154699519 | CID_154699519 | |
| 0.191 | 0.005 | 0.191 | NMDA receptor agonist | |||
| 0.19 | 0.004 | 0.257 | Leukotriene B4 antagonist | 0.257 0.003 CID_154699774 0.257 0.003 CID_154699519 | CID_154699519 | |
| 0.189 | 0.003 | 0.189 | Aconitate hydratase inhibitor | |||
| 0.196 | 0.012 | 0.52 | AMP-activated protein kinase stimulant | 0.52 0.003 CID_154699774 0.52 0.003 CID_154699519 | CID_154699519 | |
| 0.195 | 0.013 | 0.195 | Alcohol dehydrogenase inhibitor | 0.138 0.025 CID_154699774 0.138 0.025 CID_154699519 | ||
| 0.235 | 0.052 | 0.235 | Sigma receptor agonist | |||
| 0.211 | 0.03 | 0.211 | Neurotensin receptor agonist | |||
| 0.246 | 0.065 | 0.457 | Cyclic AMP phosphodiesterase inhibitor | 0.457 0.01 CID_154699774 0.457 0.01 CID_154699519 | CID_154699519 | |
| 0.188 | 0.008 | 0.188 | Vanilloid agonist | 0.101 0.032 CID_154699774 0.101 0.032 CID_154699519 | ||
| 0.194 | 0.016 | 0.194 | Adenylate kinase inhibitor | 0.111 0.052 CID_154699774 0.111 0.052 CID_154699519 | ||
| 0.185 | 0.008 | 0.185 | CDC25A inhibitor | 0.078 0.045 CID_154699774 0.078 0.045 CID_154699519 | ||
| 0.219 | 0.043 | 0.407 | Thrombolytic | 0.407 0.01 CID_154699774 0.407 0.01 CID_154699519 | CID_154699519 | |
| 0.184 | 0.009 | 0.184 | Estrogen receptor alpha antagonist | |||
| 0.234 | 0.06 | 0.234 | RNA-directed DNA polymerase inhibitor | 0.198 0.103 CID_154699774 0.198 0.103 CID_154699519 | ||
| 0.182 | 0.01 | 0.183 | Thioredoxin inhibitor | 0.183 0.01 CID_154699774 0.183 0.01 CID_154699519 | CID_154699519 | |
| 0.179 | 0.008 | 0.179 | Peroxisome proliferator-activated receptor gamma agonist | 0.09 0.034 CID_154699774 0.09 0.034 CID_154699519 | ||
| 0.282 | 0.113 | 0.282 | Thioredoxin glutathione reductase inhibitor | |||
| 0.177 | 0.008 | 0.177 | Prostaglandin antagonist | |||
| 0.172 | 0.003 | 0.172 | Catechol O-methyltransferase inhibitor | 0.035 0.019 CID_154699774 0.035 0.019 CID_154699519 | ||
| 0.177 | 0.008 | 0.177 | Ca2+-transporting ATPase inhibitor | 0.164 0.018 CID_154699774 0.164 0.018 CID_154699519 | ||
| 0.237 | 0.069 | 0.237 | Neuropeptide Y2 antagonist | |||
| 0.197 | 0.031 | 0.346 | Cell wall synthesis inhibitor | 0.346 0.008 CID_154699774 0.346 0.008 CID_154699519 | CID_154699519 | |
| 0.19 | 0.025 | 0.19 | Interleukin 4 antagonist | 0.175 0.032 CID_154699774 0.175 0.032 CID_154699519 | ||
| 0.188 | 0.023 | 0.438 | Cyclooxygenase 3 inhibitor | 0.438 0.004 CID_154699774 0.438 0.004 CID_154699519 | CID_154699519 | |
| 0.252 | 0.088 | 0.252 | 5 Hydroxytryptamine release stimulant | 0.18 0.141 CID_154699774 0.18 0.141 CID_154699519 | ||
| 0.188 | 0.026 | 0.188 | Farnesoid X receptor antagonist | |||
| 0.173 | 0.013 | 0.274 | NADH dehydrogenase inhibitor | 0.274 0.007 CID_154699774 0.274 0.007 CID_154699519 | CID_154699519 | |
| 0.168 | 0.01 | 0.168 | Estrogen agonist | 0.127 0.013 CID_154699774 0.127 0.013 CID_154699519 | ||
| 0.161 | 0.005 | 0.161 | Plasminogen activator inhibitor antagonist | |||
| 0.162 | 0.008 | 0.162 | Biliverdin reductase inhibitor | 0.065 0.036 CID_154699774 0.065 0.036 CID_154699519 | ||
| 0.175 | 0.022 | 0.334 | UDP-glucose 4-epimerase inhibitor | 0.334 0.009 CID_154699774 0.334 0.009 CID_154699519 | CID_154699519 | |
| 0.163 | 0.011 | 0.163 | Beta tubulin antagonist | |||
| 0.18 | 0.028 | 0.18 | MAO B inhibitor | |||
| 0.171 | 0.023 | 0.171 | Interleukin 8 antagonist | |||
| 0.155 | 0.008 | 0.155 | Prostaglandin E2 antagonist | |||
| 0.303 | 0.16 | 0.303 | DNA directed DNA polymerase inhibitor | |||
| 0.149 | 0.006 | 0.149 | CDC25B inhibitor | |||
| 0.156 | 0.014 | 0.156 | Estrogen receptor beta antagonist | |||
| 0.145 | 0.003 | 0.145 | Retinoid X alpha receptor agonist | |||
| 0.143 | 0.004 | 0.143 | Prostaglandin agonist | 0.028 0.025 CID_154699774 0.028 0.025 CID_154699519 | ||
| 0.159 | 0.022 | 0.159 | Caspase 3 inhibitor | |||
| 0.152 | 0.015 | 0.238 | Cell adhesion molecule inhibitor | 0.238 0.007 CID_154699774 0.238 0.007 CID_154699519 | CID_154699519 | |
| 0.179 | 0.043 | 0.189 | Alkaline phosphatase inhibitor | 0.189 0.038 CID_154699774 0.189 0.038 CID_154699519 | CID_154699519 | |
| 0.157 | 0.022 | 0.157 | Breast cancer-resistant protein inhibitor | |||
| 0.136 | 0.004 | 0.154 | Glucose-6-phosphate translocase inhibitor | 0.154 0.003 CID_154699774 0.154 0.003 CID_154699519 | CID_154699519 | |
| 0.167 | 0.036 | 0.167 | Cathepsin H inhibitor | |||
| 0.167 | 0.037 | 0.167 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.166 | 0.035 | 0.166 | Antibacterial (Helicobacter pylori) | 0.112 0.095 CID_154699774 0.112 0.095 CID_154699519 | ||
| 0.168 | 0.038 | 0.31 | Alkylator | 0.31 0.012 CID_154699774 0.31 0.012 CID_154699519 | CID_154699519 | |
| 0.133 | 0.003 | 0.133 | Retinoid X receptor agonist | |||
| 0.156 | 0.028 | 0.156 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.295 | 0.168 | 0.295 | DNA polymerase beta inhibitor | |||
| 0.133 | 0.007 | 0.133 | Carbonic anhydrase VII inhibitor | 0.075 0.014 CID_154699774 0.075 0.014 CID_154699519 | ||
| 0.132 | 0.006 | 0.132 | NMDA receptor glycine site agonist | |||
| 0.145 | 0.021 | 0.145 | Anabolic | |||
| 0.138 | 0.014 | 0.237 | Phosphodiesterase 6D inhibitor | 0.237 0.004 CID_154699774 0.237 0.004 CID_154699519 | CID_154699519 | |
| 0.142 | 0.019 | 0.419 | Selectin antagonist | 0.419 0.003 CID_154699774 0.419 0.003 CID_154699519 | CID_154699519 | |
| 0.131 | 0.009 | 0.22 | Phosphorylase inhibitor | 0.22 0.004 CID_154699774 0.22 0.004 CID_154699519 | CID_154699519 | |
| 0.13 | 0.01 | 0.13 | Purinergic P2X1 antagonist | 0.059 0.045 CID_154699774 0.059 0.045 CID_154699519 | ||
| 0.124 | 0.006 | 0.124 | GABA B receptor agonist | |||
| 0.149 | 0.032 | 0.258 | DNA repair enzyme inhibitor | 0.258 0.005 CID_154699774 0.258 0.005 CID_154699519 | CID_154699519 | |
| 0.148 | 0.031 | 0.148 | GABA C receptor antagonist | |||
| 0.121 | 0.004 | 0.121 | Retinoic acid alpha receptor agonist | 0.055 0.011 CID_154699774 0.055 0.011 CID_154699519 | ||
| 0.119 | 0.004 | 0.119 | Leukotriene B4 receptor 1 antagonist | 0.059 0.005 CID_154699774 0.059 0.005 CID_154699519 | ||
| 0.129 | 0.014 | 0.129 | Leukotriene synthesis inhibitor | |||
| 0.119 | 0.004 | 0.119 | Retinoic acid receptor agonist | 0.034 0.008 CID_154699774 0.034 0.008 CID_154699519 | ||
| 0.116 | 0.003 | 0.116 | Retinoid X beta receptor agonist | 0.023 0.012 CID_154699774 0.023 0.012 CID_154699519 | ||
| 0.15 | 0.038 | 0.15 | Aminopeptidase B inhibitor | |||
| 0.145 | 0.034 | 0.183 | Photosensitizer | 0.183 0.017 CID_154699774 0.183 0.017 CID_154699519 | CID_154699519 | |
| 0.115 | 0.003 | 0.115 | Retinoid X gamma receptor agonist | 0.027 0.012 CID_154699774 0.027 0.012 CID_154699519 | ||
| 0.166 | 0.055 | 0.166 | GABA C receptor rho-2 antagonist | |||
| 0.159 | 0.048 | 0.159 | Cyclooxygenase 2 inhibitor | 0.11 0.091 CID_154699774 0.11 0.091 CID_154699519 | ||
| 0.12 | 0.01 | 0.12 | Maillard reaction inhibitor | 0.069 0.029 CID_154699774 0.069 0.029 CID_154699519 | ||
| 0.114 | 0.005 | 0.114 | Thromboxane synthase inhibitor | |||
| 0.119 | 0.01 | 0.119 | Estrogen-related receptor beta agonist | |||
| 0.177 | 0.069 | 0.177 | Tumour necrosis factor antagonist | |||
| 0.218 | 0.11 | 0.218 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.12 | 0.013 | 0.12 | D-Ala-D-Ala ligase inhibitor | |||
| 0.121 | 0.015 | 0.121 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.109 | 0.004 | 0.125 | Glucose-6-phosphate isomerase inhibitor | 0.125 0.003 CID_154699774 0.125 0.003 CID_154699519 | CID_154699519 | |
| 0.122 | 0.018 | 0.122 | Bile acid receptor antagonist | |||
| 0.143 | 0.039 | 0.143 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.122 | 0.018 | 0.142 | ATPase (Vacuolar H+) inhibitor | 0.142 0.01 CID_154699774 0.142 0.01 CID_154699519 | CID_154699519 | |
| 0.113 | 0.01 | 0.113 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.12 | 0.017 | 0.12 | Thioredoxin reductase inhibitor | 0.078 0.066 CID_154699774 0.078 0.066 CID_154699519 | ||
| 0.119 | 0.017 | 0.119 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.147 | 0.045 | 0.147 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.116 | 0.014 | 0.116 | Glycine receptor agonist | 0.087 0.031 CID_154699774 0.087 0.031 CID_154699519 | ||
| 0.105 | 0.004 | 0.105 | Prostaglandin E2 agonist | |||
| 0.103 | 0.003 | 0.103 | Kainate receptor agonist | 0.042 0.027 CID_154699774 0.042 0.027 CID_154699519 | ||
| 0.188 | 0.088 | 0.188 | Histone acetyltransferase inhibitor | |||
| 0.133 | 0.034 | 0.133 | Potassium channel (Ca-activated) activator | |||
| 0.142 | 0.043 | 0.142 | MAO A inhibitor | |||
| 0.105 | 0.007 | 0.105 | Exportin-1 inhibitor | |||
| 0.162 | 0.065 | 0.245 | Hexokinase inhibitor | 0.245 0.018 CID_154699774 0.245 0.018 CID_154699519 | CID_154699519 | |
| 0.132 | 0.035 | 0.132 | Gastric antisecretory | |||
| 0.129 | 0.033 | 0.129 | GABA C receptor rho-1 antagonist | |||
| 0.101 | 0.005 | 0.101 | Fumarate hydratase inhibitor | 0.041 0.018 CID_154699774 0.041 0.018 CID_154699519 | ||
| 0.106 | 0.01 | 0.106 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.109 | 0.014 | 0.109 | Alpha tubulin antagonist | |||
| 0.275 | 0.18 | 0.275 | Calcium channel L-type activator | |||
| 0.134 | 0.039 | 0.134 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.01 | 0.104 | Thromboxane antagonist | |||
| 0.231 | 0.138 | 0.231 | Prostaglandin dehydrogenase inhibitor | |||
| 0.111 | 0.023 | 0.13 | Na+ K+ transporting ATPase inhibitor | 0.13 0.011 CID_154699774 0.13 0.011 CID_154699519 | CID_154699519 | |
| 0.09 | 0.003 | 0.09 | Retinoic acid alpha receptor antagonist | 0.027 0.008 CID_154699774 0.027 0.008 CID_154699519 | ||
| 0.122 | 0.035 | 0.122 | NMDA receptor antagonist | |||
| 0.092 | 0.005 | 0.092 | Leukotriene C antagonist | |||
| 0.141 | 0.054 | 0.298 | Topoisomerase II inhibitor | 0.298 0.018 CID_154699774 0.298 0.018 CID_154699519 | CID_154699519 | |
| 0.091 | 0.005 | 0.091 | Prostaglandin EP4 antagonist | |||
| 0.149 | 0.063 | 0.149 | Cytokine production inhibitor | |||
| 0.094 | 0.009 | 0.094 | Heme oxygenase stimulant | 0.061 0.043 CID_154699774 0.061 0.043 CID_154699519 | ||
| 0.094 | 0.009 | 0.094 | Thromboxane A2 antagonist | |||
| 0.089 | 0.004 | 0.089 | LFA antagonist | |||
| 0.164 | 0.079 | 0.164 | Antipruritic | |||
| 0.103 | 0.018 | 0.103 | Argininosuccinate synthase inhibitor | |||
| 0.1 | 0.016 | 0.1 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.11 | 0.026 | 0.11 | Myeloperoxidase inhibitor | |||
| 0.1 | 0.016 | 0.1 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.107 | 0.024 | 0.107 | Aminopeptidase I inhibitor | |||
| 0.112 | 0.029 | 0.112 | Cathepsin G inhibitor | |||
| 0.091 | 0.01 | 0.091 | Estrogen receptor alpha agonist | |||
| 0.087 | 0.006 | 0.087 | Factor III inhibitor | 0.081 0.007 CID_154699774 0.081 0.007 CID_154699519 | ||
| 0.094 | 0.014 | 0.094 | Prostaglandin F2 alpha antagonist | |||
| 0.088 | 0.008 | 0.088 | Squalene epoxidase inhibitor | 0.06 0.02 CID_154699774 0.06 0.02 CID_154699519 | ||
| 0.081 | 0.003 | 0.081 | Retinoic acid receptor antagonist | 0.031 0.005 CID_154699774 0.031 0.005 CID_154699519 | ||
| 0.102 | 0.024 | 0.102 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.143 | 0.065 | 0.143 | Bone formation stimulant | 0.105 0.101 CID_154699774 0.105 0.101 CID_154699519 | ||
| 0.08 | 0.003 | 0.08 | Retinoid X receptor antagonist | |||
| 0.088 | 0.012 | 0.088 | Glutamate (mGluR group III) agonist | |||
| 0.081 | 0.004 | 0.081 | Glutamate (mGluR8) agonist | |||
| 0.116 | 0.04 | 0.116 | Electrolyte absorption antagonist | |||
| 0.082 | 0.006 | 0.082 | Dopamine D5 agonist | |||
| 0.08 | 0.004 | 0.08 | Prostaglandin EP2 agonist | 0.029 0.013 CID_154699774 0.029 0.013 CID_154699519 | ||
| 0.088 | 0.013 | 0.088 | Botulinum neurotoxin type A inhibitor | |||
| 0.102 | 0.027 | 0.144 | Histone deacetylase SIRT1 stimulant | 0.144 0.01 CID_154699774 0.144 0.01 CID_154699519 | CID_154699519 | |
| 0.102 | 0.027 | 0.144 | Histone deacetylase stimulant | 0.144 0.01 CID_154699774 0.144 0.01 CID_154699519 | CID_154699519 | |
| 0.18 | 0.107 | 0.18 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.08 | 0.008 | 0.08 | Adenylate cyclase 1 inhibitor | |||
| 0.075 | 0.003 | 0.075 | ICAM 1 antagonist | |||
| 0.139 | 0.069 | 0.139 | Neurotrophic factor | 0.114 0.106 CID_154699774 0.114 0.106 CID_154699519 | ||
| 0.083 | 0.014 | 0.083 | Estrogen receptor beta agonist | 0.053 0.019 CID_154699774 0.053 0.019 CID_154699519 | ||
| 0.104 | 0.036 | 0.104 | Metalloproteinase-2 inhibitor | |||
| 0.086 | 0.018 | 0.086 | Glutamate (mGluR6) antagonist | |||
| 0.089 | 0.021 | 0.089 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.071 | 0.004 | 0.071 | ATP citrate lysase inhibitor | |||
| 0.073 | 0.007 | 0.073 | RNA-directed RNA polymerase inhibitor | |||
| 0.081 | 0.016 | 0.081 | Transcription factor RelA inhibitor | |||
| 0.142 | 0.078 | 0.142 | Thiol protease inhibitor | |||
| 0.107 | 0.043 | 0.107 | Calcium antagonist | |||
| 0.073 | 0.01 | 0.243 | Heparanase inhibitor | 0.243 0.002 CID_154699774 0.243 0.002 CID_154699519 | CID_154699519 | |
| 0.066 | 0.003 | 0.066 | Retinoid X alpha receptor antagonist | |||
| 0.114 | 0.051 | 0.114 | Urease inhibitor | |||
| 0.075 | 0.013 | 0.075 | Dihydroorotate oxidase inhibitor | |||
| 0.067 | 0.005 | 0.067 | NMDA 2D receptor antagonist | |||
| 0.1 | 0.039 | 0.218 | Topoisomerase II alpha inhibitor | 0.218 0.013 CID_154699774 0.218 0.013 CID_154699519 | CID_154699519 | |
| 0.083 | 0.023 | 0.113 | Neuraminidase inhibitor | 0.113 0.011 CID_154699774 0.113 0.011 CID_154699519 | CID_154699519 | |
| 0.072 | 0.012 | 0.072 | Pregnane X receptor antagonist | |||
| 0.065 | 0.005 | 0.065 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.083 | 0.023 | 0.083 | NMDA 2C receptor antagonist | |||
| 0.164 | 0.105 | 0.164 | Psychostimulant | 0.155 0.112 CID_154699774 0.155 0.112 CID_154699519 | ||
| 0.148 | 0.089 | 0.148 | Growth hormone agonist | |||
| 0.064 | 0.005 | 0.064 | Leukotriene C4 antagonist | |||
| 0.097 | 0.039 | 0.097 | Inducible nitric-oxide synthase inhibitor | |||
| 0.082 | 0.024 | 0.13 | Neuraminidase (influenza) inhibitor | 0.13 0.01 CID_154699774 0.13 0.01 CID_154699519 | CID_154699519 | |
| 0.062 | 0.004 | 0.062 | Retinoic acid beta receptor agonist | 0.019 0.015 CID_154699774 0.019 0.015 CID_154699519 | ||
| 0.071 | 0.014 | 0.071 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.154 | 0.097 | 0.154 | Catenin beta inhibitor | |||
| 0.061 | 0.004 | 0.061 | Leukotriene B4 receptor 2 antagonist | 0.044 0.005 CID_154699774 0.044 0.005 CID_154699519 | ||
| 0.093 | 0.036 | 0.093 | Metalloproteinase-9 inhibitor | |||
| 0.071 | 0.015 | 0.079 | Adenine nucleotide translocase inhibitor | 0.079 0.009 CID_154699774 0.079 0.009 CID_154699519 | CID_154699519 | |
| 0.066 | 0.01 | 0.066 | Kainate receptor 2 antagonist | |||
| 0.071 | 0.016 | 0.071 | DNA helicase inhibitor | |||
| 0.244 | 0.19 | 0.244 | Transcription factor inhibitor | |||
| 0.058 | 0.005 | 0.058 | Prostaglandin EP4 agonist | |||
| 0.073 | 0.02 | 0.073 | Glycine transporter 2 inhibitor | |||
| 0.056 | 0.003 | 0.056 | Retinoic acid gamma receptor agonist | 0.025 0.01 CID_154699774 0.025 0.01 CID_154699519 | ||
| 0.085 | 0.033 | 0.085 | MAP kinase kinase 7 inhibitor | |||
| 0.067 | 0.016 | 0.067 | Vanilloid 2 antagonist | |||
| 0.067 | 0.017 | 0.067 | CD45 antagonist | |||
| 0.053 | 0.003 | 0.053 | Retinoid X gamma receptor antagonist | 0.033 0.009 CID_154699774 0.033 0.009 CID_154699519 | ||
| 0.074 | 0.024 | 0.074 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.059 | 0.01 | 0.059 | Prostacyclin antagonist | |||
| 0.053 | 0.004 | 0.053 | Thyroid hormone agonist | |||
| 0.136 | 0.087 | 0.419 | Hemostatic | 0.419 0.007 CID_154699774 0.419 0.007 CID_154699519 | CID_154699519 | |
| 0.135 | 0.086 | 0.135 | Pregnane X receptor agonist | |||
| 0.078 | 0.03 | 0.078 | Glutamate (mGluR7) antagonist | |||
| 0.057 | 0.009 | 0.057 | Leukotriene D4 antagonist | |||
| 0.059 | 0.01 | 0.059 | Farnesoid X receptor agonist | |||
| 0.094 | 0.046 | 0.188 | Transcription factor NF kappa B stimulant | 0.188 0.01 CID_154699774 0.188 0.01 CID_154699519 | CID_154699519 | |
| 0.075 | 0.027 | 0.075 | MDM2 inhibitor | |||
| 0.058 | 0.011 | 0.058 | GABA uptake inhibitor | |||
| 0.101 | 0.054 | 0.101 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.052 | 0.006 | 0.052 | Integrin alpha1beta1 antagonist | |||
| 0.071 | 0.025 | 0.071 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.064 0.03 CID_154699774 0.064 0.03 CID_154699519 | ||
| 0.056 | 0.011 | 0.056 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.06 | 0.015 | 0.06 | Dopamine beta hydroxylase inhibitor | |||
| 0.059 | 0.017 | 0.059 | Kainate receptor antagonist | |||
| 0.078 | 0.037 | 0.078 | Elastase 1 inhibitor | |||
| 0.068 | 0.027 | 0.068 | Ornithine carbamoyltransferase inhibitor | |||
| 0.113 | 0.072 | 0.113 | Anesthetic local | |||
| 0.044 | 0.005 | 0.044 | Prostaglandin H2 antagonist | |||
| 0.092 | 0.053 | 0.092 | Androgen antagonist | |||
| 0.081 | 0.042 | 0.081 | Lipase inhibitor | |||
| 0.065 | 0.026 | 0.065 | Ryanodine receptor antagonist | |||
| 0.04 | 0.004 | 0.04 | Retinoic acid beta receptor antagonist | |||
| 0.039 | 0.003 | 0.039 | Retinoid X beta receptor antagonist | |||
| 0.069 | 0.034 | 0.091 | Nitric oxide donor | 0.091 0.014 CID_154699774 0.091 0.014 CID_154699519 | CID_154699519 | |
| 0.04 | 0.005 | 0.04 | Prostaglandin F2 alpha agonist | |||
| 0.043 | 0.008 | 0.043 | Glutamate (mGluR3) agonist | |||
| 0.044 | 0.01 | 0.044 | Prostaglandin D2 agonist | |||
| 0.092 | 0.057 | 0.092 | Glutamate release inhibitor | 0.089 0.064 CID_154699774 0.089 0.064 CID_154699519 | ||
| 0.05 | 0.016 | 0.05 | Membrane dipeptidase inhibitor | |||
| 0.038 | 0.004 | 0.038 | Integrin beta2 antagonist | |||
| 0.129 | 0.095 | 0.229 | Diuretic | 0.229 0.035 CID_154699774 0.229 0.035 CID_154699519 | CID_154699519 | |
| 0.052 | 0.019 | 0.052 | Guanylate cyclase inhibitor | 0.048 0.023 CID_154699774 0.048 0.023 CID_154699519 | ||
| 0.043 | 0.011 | 0.043 | HMG CoA reductase inhibitor | 0.035 0.022 CID_154699774 0.035 0.022 CID_154699519 | ||
| 0.077 | 0.045 | 0.077 | NMDA 2 receptor antagonist | |||
| 0.071 | 0.039 | 0.071 | Carbonic anhydrase inhibitor | 0.065 0.043 CID_154699774 0.065 0.043 CID_154699519 | ||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | |||
| 0.044 | 0.013 | 0.044 | Glutamate (mGluR4) agonist | |||
| 0.047 | 0.017 | 0.07 | Arginase inhibitor | 0.07 0.008 CID_154699774 0.07 0.008 CID_154699519 | CID_154699519 | |
| 0.039 | 0.009 | 0.039 | NMDA receptor glycine site antagonist | |||
| 0.094 | 0.064 | 0.136 | Interleukin 12 antagonist | 0.136 0.018 CID_154699774 0.136 0.018 CID_154699519 | CID_154699519 | |
| 0.041 | 0.012 | 0.041 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.084 | 0.054 | 0.261 | Antineoplastic antibiotic | 0.261 0.013 CID_154699774 0.261 0.013 CID_154699519 | CID_154699519 | |
| 0.033 | 0.004 | 0.033 | Retinoic acid receptor gamma antagonist | 0.012 0.007 CID_154699774 0.012 0.007 CID_154699519 | ||
| 0.045 | 0.018 | 0.045 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.041 | 0.014 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.034 | 0.007 | 0.034 | Integrin beta5 antagonist | |||
| 0.106 | 0.079 | 0.106 | Proteasome inhibitor | |||
| 0.03 | 0.003 | 0.03 | Glutamate (mGluR6) agonist | |||
| 0.107 | 0.081 | 0.134 | Beta amyloid protein antagonist | 0.134 0.053 CID_154699774 0.134 0.053 CID_154699519 | CID_154699519 | |
| 0.064 | 0.039 | 0.064 | Caspase 9 inhibitor | |||
| 0.029 | 0.004 | 0.029 | Integrin alphaLbeta2 antagonist | |||
| 0.039 | 0.015 | 0.039 | HCV NS5B polymerase inhibitor | |||
| 0.04 | 0.016 | 0.04 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.043 | 0.019 | 0.043 | Nicotinic acid receptor agonist | |||
| 0.046 | 0.023 | 0.046 | Liver X receptor alpha agonist | |||
| 0.092 | 0.069 | 0.092 | Sphingomyelinase inhibitor | |||
| 0.067 | 0.043 | 0.067 | Beta adrenoreceptor antagonist | |||
| 0.056 | 0.033 | 0.093 | Alpha-mannosidase inhibitor | 0.093 0.008 CID_154699774 0.093 0.008 CID_154699519 | CID_154699519 | |
| 0.049 | 0.026 | 0.049 | NMDA receptor subunit 3B antagonist | |||
| 0.052 | 0.029 | 0.052 | Topoisomerase II beta inhibitor | |||
| 0.065 | 0.043 | 0.065 | Beta 3 adrenoreceptor antagonist | |||
| 0.032 | 0.009 | 0.032 | Kainate receptor 1 antagonist | |||
| 0.115 | 0.093 | 0.115 | Toll-Like receptor antagonist | |||
| 0.033 | 0.011 | 0.033 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.079 | 0.058 | 0.12 | Glycine receptor antagonist | 0.12 0.018 CID_154699774 0.12 0.018 CID_154699519 | CID_154699519 | |
| 0.132 | 0.112 | 0.132 | CF transmembrane conductance regulator agonist | |||
| 0.042 | 0.022 | 0.042 | 5-Alpha-reductase inhibitor | |||
| 0.057 | 0.038 | 0.057 | Beta 1 adrenoreceptor antagonist | |||
| 0.055 | 0.036 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.034 | 0.015 | 0.034 | Uridine phosphorylase inhibitor | 0.025 0.023 CID_154699774 0.025 0.023 CID_154699519 | ||
| 0.062 | 0.043 | 0.062 | Beta 2 adrenoreceptor agonist | |||
| 0.14 | 0.121 | 0.14 | Lipocortins synthesis antagonist | |||
| 0.054 | 0.036 | 0.054 | Matrix metalloproteinase 1 inhibitor | |||
| 0.029 | 0.011 | 0.044 | Vanilloid 2 agonist | 0.044 0.003 CID_154699774 0.044 0.003 CID_154699519 | CID_154699519 | |
| 0.046 | 0.028 | 0.046 | Dihydroorotase inhibitor | |||
| 0.046 | 0.029 | 0.046 | Integrin antagonist | |||
| 0.041 | 0.024 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.041 | 0.024 | 0.041 | NMDA receptor subunit 3A antagonist | |||
| 0.038 | 0.021 | 0.038 | Glutamate (mGluR8) antagonist | |||
| 0.03 | 0.013 | 0.03 | Nicotinic acid receptor 2 antagonist | |||
| 0.037 | 0.02 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.031 | 0.015 | 0.031 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.021 | 0.005 | 0.021 | Thromboxane A2 agonist | |||
| 0.055 | 0.039 | 0.055 | Carbonic anhydrase II inhibitor | |||
| 0.04 | 0.025 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.167 | 0.152 | 0.167 | Calpain inhibitor | |||
| 0.026 | 0.011 | 0.026 | Prostaglandin EP1 antagonist | |||
| 0.035 | 0.021 | 0.035 | Tubulin agonist | |||
| 0.082 | 0.068 | 0.084 | Interleukin 5 antagonist | 0.084 0.065 CID_154699774 0.084 0.065 CID_154699519 | CID_154699519 | |
| 0.1 | 0.087 | 0.1 | Acetylcholine release stimulant | |||
| 0.065 | 0.051 | 0.065 | Sirtuin 1 inhibitor | |||
| 0.017 | 0.004 | 0.017 | Thyroid hormone beta agonist | |||
| 0.057 | 0.044 | 0.057 | Sphingosine kinase inhibitor | |||
| 0.05 | 0.037 | 0.05 | Beta 2 adrenoreceptor antagonist | |||
| 0.017 | 0.004 | 0.017 | Thromboxane agonist | |||
| 0.037 | 0.025 | 0.037 | Glutamate (mGluR3) antagonist | |||
| 0.132 | 0.12 | 0.2 | Interleukin 6 antagonist | 0.2 0.041 CID_154699774 0.2 0.041 CID_154699519 | CID_154699519 | |
| 0.028 | 0.015 | 0.028 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.024 | 0.012 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.026 | 0.014 | 0.026 | Prostaglandin D2 antagonist | |||
| 0.044 | 0.033 | 0.091 | Mannosidase inhibitor | 0.091 0.007 CID_154699774 0.091 0.007 CID_154699519 | CID_154699519 | |
| 0.02 | 0.009 | 0.02 | Prostacyclin agonist | |||
| 0.062 | 0.051 | 0.062 | Matrix metalloproteinase inhibitor | |||
| 0.051 | 0.04 | 0.051 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.029 | 0.018 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.052 | 0.041 | 0.072 | Carbonic anhydrase IX inhibitor | 0.072 0.031 CID_154699774 0.072 0.031 CID_154699519 | CID_154699519 | |
| 0.148 | 0.138 | 0.148 | Aryl hydrocarbon receptor agonist | |||
| 0.033 | 0.023 | 0.033 | Histone deacetylase 5 inhibitor | |||
| 0.048 | 0.039 | 0.048 | Prolyl endopeptidase inhibitor | |||
| 0.045 | 0.035 | 0.045 | Antimetabolite | |||
| 0.051 | 0.042 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.066 | 0.057 | 0.066 | Telomerase inhibitor | |||
| 0.052 | 0.044 | 0.052 | Sphingosine kinase 2 inhibitor | |||
| 0.033 | 0.025 | 0.033 | Free fatty acid receptor 1 antagonist | |||
| 0.04 | 0.032 | 0.04 | Carbonic anhydrase IV inhibitor | |||
| 0.02 | 0.013 | 0.02 | 5-Alpha-reductase 2 inhibitor | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.063 | 0.056 | 0.063 | HIV-1 reverse transcriptase inhibitor | |||
| 0.017 | 0.011 | 0.017 | Thyroid hormone alpha agonist | |||
| 0.051 | 0.045 | 0.051 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.062 | 0.056 | 0.062 | Potassium channel large-conductance Ca-activated activator | |||
| 0.113 | 0.108 | 0.113 | Cytidine deaminase inhibitor | |||
| 0.04 | 0.035 | 0.04 | GABA B receptor antagonist | |||
| 0.016 | 0.012 | 0.016 | Vitamin D receptor agonist | |||
| 0.045 | 0.042 | 0.096 | Carbonic anhydrase XII inhibitor | 0.096 0.021 CID_154699774 0.096 0.021 CID_154699519 | CID_154699519 | |
| 0.041 | 0.037 | 0.041 | AICAR transformylase inhibitor | |||
| 0.053 | 0.05 | 0.053 | Carbonic anhydrase stimulant | |||
| 0.181 | 0.178 | 0.181 | Thyroid hormone antagonist | |||
| 0.021 | 0.019 | 0.032 | Dopamine D1 agonist | 0.032 0.008 CID_154699774 0.032 0.008 CID_154699519 | CID_154699519 | |
| 0.013 | 0.01 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.023 | 0.021 | 0.023 | Glutamate (mGluR1) agonist | |||
| 0.006 | 0.004 | 0.006 | Insulin like growth factor 3 antagonist | |||
| 0.014 | 0.012 | 0.014 | Thyroid hormone alpha antagonist | |||
| 0.016 | 0.014 | 0.021 | Telomerase stimulant | 0.021 0.007 CID_154699774 0.021 0.007 CID_154699519 | CID_154699519 | |
| 0.024 | 0.023 | 0.024 | Urotensin II agonist | |||
| 0.024 | 0.023 | 0.024 | Lysine carboxypeptidase inhibitor | |||
| 0.02 | 0.019 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.026 | 0.028 | 0.051 | Squalene synthetase inhibitor | 0.051 0.014 CID_154699774 0.051 0.014 CID_154699519 | CID_154699519 | |
| 0.017 | 0.021 | 0.028 | Antibiotic Anthracycline-like | 0.028 0.004 CID_154699774 0.028 0.004 CID_154699519 | CID_154699519 | |
| 0.021 | 0.031 | 0.095 | Sodium/glucose cotransporter 2 inhibitor | 0.095 0.003 CID_154699774 0.095 0.003 CID_154699519 | CID_154699519 | |
| 0.037 | 0.049 | 0.055 | Microtubule stabilization | 0.055 0.022 CID_154699774 0.055 0.022 CID_154699519 | CID_154699519 | |
| 0.051 | 0.066 | 0.068 | Lipocortins synthesis agonist | 0.068 0.024 CID_154699774 0.068 0.024 CID_154699519 | CID_154699519 | |
| 0.021 | 0.036 | 0.082 | Sodium/glucose cotransporter inhibitor | 0.082 0.003 CID_154699774 0.082 0.003 CID_154699519 | CID_154699519 | |
| 0.01 | 0.027 | 0.027 | Ileal bile acid transport inhibitor | 0.027 0.005 CID_154699774 0.027 0.005 CID_154699519 | CID_154699519 | |
| 0.035 | 0.056 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.057 0.015 CID_154699774 0.057 0.015 CID_154699519 | CID_154699519 | |
| 0.083 | 0.114 | 0.125 | Multidrug resistance-associated protein 1 inhibitor | 0.125 0.043 CID_154699774 0.125 0.043 CID_154699519 | CID_154699519 | |
| 0.06 | 0.092 | 0.075 | Phosphodiesterase VI inhibitor | 0.075 0.05 CID_154699774 0.075 0.05 CID_154699519 | CID_154699519 | |
| 0.17 | 0.208 | 0.271 | Angiogenesis inhibitor | 0.271 0.109 CID_154699774 0.271 0.109 CID_154699519 | CID_154699519 | |
| 0.011 | 0.05 | 0.019 | Corticosteroid-like | 0.019 0.018 CID_154699774 0.019 0.018 CID_154699519 | CID_154699519 | |
| 0.062 | 0.103 | 0.11 | Falcipain 2 inhibitor | 0.11 0.047 CID_154699774 0.11 0.047 CID_154699519 | CID_154699519 | |
| 0.019 | 0.061 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.014 CID_154699774 0.031 0.014 CID_154699519 | CID_154699519 | |
| 0.064 | 0.106 | 0.111 | Falcipain inhibitor | 0.111 0.048 CID_154699774 0.111 0.048 CID_154699519 | CID_154699519 | |
| 0.065 | 0.11 | 0.238 | Topoisomerase I inhibitor | 0.238 0.019 CID_154699774 0.238 0.019 CID_154699519 | CID_154699519 | |
| 0.03 | 0.081 | 0.114 | Protein 50S ribosomal subunit inhibitor | 0.114 0.01 CID_154699774 0.114 0.01 CID_154699519 | CID_154699519 | |
| 0.002 | 0.082 | 0.012 | Antibiotic Macrolide-like | 0.012 0.011 CID_154699774 0.012 0.011 CID_154699519 | CID_154699519 | |
| 0.01 | 0.153 | 0.057 | Protein 30S ribosomal subunit inhibitor | 0.057 0.007 CID_154699774 0.057 0.007 CID_154699519 | CID_154699519 | |
| 0.019 | 0.172 | 0.077 | Antibiotic Aminoglycoside-like | 0.077 0.005 CID_154699774 0.077 0.005 CID_154699519 | CID_154699519 | |
| 0.128 | 0.321 | 0.273 | Toll-Like receptor 7 agonist | 0.273 0.128 CID_154699774 0.273 0.128 CID_154699519 | CID_154699519 | |
| 0.059 | 0.256 | 0.254 | Anticoagulant | 0.254 0.038 CID_154699774 0.254 0.038 CID_154699519 | CID_154699519 | |
| 0.12 | 0.336 | 0.291 | Toll-Like receptor agonist | 0.291 0.116 CID_154699774 0.291 0.116 CID_154699519 | CID_154699519 | |
| 0.022 | 0.266 | 0.077 | Factor IXa inhibitor | 0.077 0.017 CID_154699774 0.077 0.017 CID_154699519 | CID_154699519 | |
| 0.094 | 0.345 | 0.141 | CC chemokine 6 receptor antagonist | 0.141 0.037 CID_154699774 0.141 0.037 CID_154699519 | CID_154699519 | |
| 0.047 | 0.351 | 0.079 | T cell inhibitor | 0.079 0.072 CID_154699774 0.079 0.072 CID_154699519 | CID_154699519 | |
| 0.081 | 0.429 | 0.399 | Immunomodulator | 0.399 0.044 CID_154699774 0.399 0.044 CID_154699519 | CID_154699519 | |
| 0.021 | 0.387 | 0.093 | DNA intercalator | 0.093 0.081 CID_154699774 0.093 0.081 CID_154699519 | CID_154699519 | |
| 0.012 | 0.416 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.011 CID_154699774 0.031 0.011 CID_154699519 | CID_154699519 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |